Drugs / Bupivacaine-epinephrine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03950700 | Jun → Dec 2019 | impacted teeth, multiple | CES University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bupivacaine-epinephrine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03950700 ↗ |
| Known as | BUPIROP | “one of the alveolus will be irrigated with 4ml of bupivacaine 0.5% with adrenaline vasoconstrictor 1: 200,000 (BUPIROP® 0.5%), the contralateral alveolus will be irrigated with...” NCT03950700 ↗ |
| Route | Other | “one of the alveolus will be irrigated with 4ml of bupivacaine 0.5% with adrenaline vasoconstrictor 1: 200,000” NCT03950700 ↗ |